Lineage Cell Therapeutics (LCTX) Current Assets (2010 - 2026)
Lineage Cell Therapeutics (LCTX) posted Current Assets of $52.97 million for Q2 2026, up 20.8% from $43.84 million a year earlier but down 5.7% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Lineage Cell Therapeutics' Current Assets came in at $59.16 million, up 16.0% from FY2024.
- Annual Current Assets shows a five-year compound annual growth rate of 6.1% (FY2020 to FY2025).
- In prior years, Lineage Cell Therapeutics' Current Assets was $51 million in FY2024 (+32.7%), $38.44 million in FY2023 (-35.9%), $60 million in FY2022 (-46.2%) and $111.55 million in FY2021 (+153.5%).
- Quarterly Current Assets has run from a low of $34.4 million in Q3 2024 to a high of $111.55 million in Q4 2021 over five years.
- On a year-over-year basis, Current Assets has increased in each of the last seven quarters, with growth averaging 12.7% over the last eight quarters.
- The strongest year-over-year quarter for Current Assets in the past five years was Q4 2021, with growth of 153.5%; the weakest was Q4 2022, with a decline of 46.2%.
- According to Business Quant data, Current Assets for the three prior quarters was $56.16 million (Q1 2026), $59.16 million (Q4 2025) and $42.26 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Lineage Cell Therapeutics | 245.32 Mn | 43.73 Mn | - | 52.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 52.97 Mn |
| Mar 31, 2026 | 56.16 Mn |
| Dec 31, 2025 | 59.16 Mn |
| Sep 30, 2025 | 42.26 Mn |
| Jun 30, 2025 | 43.84 Mn |
| Mar 31, 2025 | 49.98 Mn |
| Dec 31, 2024 | 51.00 Mn |
| Sep 30, 2024 | 34.40 Mn |
| Jun 30, 2024 | 40.39 Mn |
| Mar 31, 2024 | 45.72 Mn |
| Dec 31, 2023 | 38.44 Mn |
| Sep 30, 2023 | 43.48 Mn |
| Jun 30, 2023 | 48.49 Mn |
| Mar 31, 2023 | 49.66 Mn |
| Dec 31, 2022 | 60.00 Mn |
| Sep 30, 2022 | 68.51 Mn |
| Jun 30, 2022 | 74.03 Mn |
| Mar 31, 2022 | 81.87 Mn |
| Dec 31, 2021 | 111.55 Mn |
| Sep 30, 2021 | 68.34 Mn |
API Access
Lineage Cell Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();